Merlintrader
Nov 16, 10:31 AM
$VIR | NEWS – Nov 13
Vir raises 150 million dollars after ECLIPSE 1 Phase 3 success. Offering priced at 10.00 dollars per share for 15 million shares, days after ECLIPSE 1 in hepatitis delta met its primary endpoint.
Source: Vir press release (Business Wire), Nov 13, 2026; 424B5, Nov 12, 2026.
Not investment advice.
Details and primary sources in our
$VIR stock hub:
https://www.merlintrader.com/vir-biotechnology-stock-hub/
0 replies